Contribution of Oncogenetics in Breast Cancer in Reunion Epidemiology of Breast Cancer in Reunion: Study of the Reunion Mutation on BRCA2

Clinical trial NCT05898009 · RECRUITING

Trial details

NCT number: NCT05898009
Sponsor: Centre Hospitalier Universitaire de la Réunion
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Genetic Disease BRCA2 Mutation

Start date: 2023-10-19
Primary completion: 2025-03-22
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.